Login
$TENX
$1.48 +$0.00 (0.0%) After hours

$TENX 8-K/A SEC Filings

Filed On Filing
30 Mar 2021 8-K/A: Financial Statements and Exhibits

See accompanying notes to the pro forma condensed combined financial statements.

08 Nov 2019 8-K/A: Submission of Matters to a Vote of Security Holders

As previously reported in the Original Form 8-K, the Company’s stockholders approved, on an advisory (nonbinding) basis and in accordance with the recommendation of the Company’s Board of Directors, two years as the frequency with which ...

22 Jan 2014 8-K/A: Financial Statements and Exhibits

See accompanying notes to the pro forma condensed combined financial statements.

20 Dec 2013 8-K/A: Submission of Matters to a Vote of Security Holders

The Company is filing this amendment to the Original Form 8-K to report that, consistent with the voting results of the stockholders at the Annual Meeting, the Company’s Board of Directors has determined to hold an advisory vote on compe...

31 Jul 2013 8-K/A: Other Events

The Company received net proceeds from the Offering of approximately $4.8 million. As a result of the Offering, the Company now has stockholders’ equity in excess of the minimum requirement of $2.5 million for continued listing on The NA...

27 Feb 2013 8-K/A: Financial Statements and Exhibits

We have acted as counsel for Oxygen Biotherapeutics, Inc., a Delaware corporation (the “Company”), in connection with the preparation of a Registration Statement on Form S-3 (333-165733) filed with the Securities and Exchange Commission ...

13 Dec 2011 8-K/A: Financial Statements and Exhibits

We have acted as counsel for Oxygen Biotherapeutics, Inc., a Delaware corporation (the “Company”), in connection with the preparation of a Registration Statement on Form S-3 (333-165733) filed with the Securities and Exchange Commission ...

26 Aug 2011 8-K/A: Departure/Election of Directors or Officers; Compensation

I am very surprised at this. I don’t agree and do not accept my termination, and I request this filing be stopped until the attorneys have talked. And then it needs to be changed.

01 Jul 2011 8-K/A: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more

This CONVERTIBLE Note AND WARRANT Purchase Agreement (this "Agreement") is made as of _____________, 2011, by and among Oxygen Biotherapeutics, Inc., a Delaware corporation (the "Company"), and the parties listed on the Schedule of Inves...

07 May 2010 8-K/A: Financial Statements and Exhibits

We have acted as counsel for Oxygen Biotherapeutics, Inc., a Delaware corporation (the “Company”), in connection with the preparation of a Registration Statement on Form S-3 (333-165733) filed March 26, 2010 and amended by Amendment No. ...

27 Jan 2009 8-K/A: Changes in Registrant's Certifying Accountant

We have read the statements made by Oxygen Biotherapeutics, Inc. (copy attached), which we understand will be filed with the Commission, pursuant to Item 4.01 of Form 8-K, as part of the Company’s Form 8-K/A report to be filed January 27...

03 Oct 2008 8-K/A: Unregistered Sales of Equity Securities; Departure/Election of Directors or Officers; Compensation

In November 2007, Oxygen Biotherapeutics, Inc., entered into an engagement letter with Chris J. Stern, Chief Executive Officer and Chairman of the Board of Directors, which provides, in part, for the issuance to him of options to purchas...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support